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ABSTRACT 
Management of Beta (β)-thalassaemia intermedia in contrast to β-thalassaemia major patients 
has no clear guidelines as to indicators of adequate transfusion. Regular blood transfusion 
suppresses bone marrow erythropoietic activity. Serum soluble transferrin receptor (sTfR) 
concentration is a marker for erythropoietic activity, with increased sTfR being associated 
with functional iron deficiency and increased erythropoietic activity. This study aimed to 
determine the use of sTfR as an indicator of adequate transfusion in adult β-thalassaemia 
intermedia patients. A cross-sectional study was conducted at Hospital Ampang, Malaysia, 
for six months. Patient group included six β-thalassaemia intermedia and 34 HbE-β-
thalassaemia transfused patients. None of the patients were on regular monthly blood 
transfusions as in β-thalassaemia major. The control group comprised of 16 healthy subjects 
with normal haematological parameters. Haemoglobin (Hb) analysis, sTfR and ferritin assays 
were performed. Hb and HbA percentages (%) were found to be significantly lower in 
patients compared to the controls, while HbE%, HbF%, sTfR and ferritin were significantly 
higher in patients. An inverse relationship was found in the controls between HbF% with Hb 
(r = -0.515, p < 0.05) and HbA% (r = -0.534, p < 0.05). In patients, sTfR showed an inverse 
relationship with HbA% (r = -0.618, p = 0.000) and a positive correlation with HbE% (r = 
0.418, p = 0.007) and HbF% (r = 0.469, p = 0.002). Multivariate analysis showed that HbA% 
(r = 2.875, p = 0.048), HbE% (r = 2.872, p = 0.020) and HbF% (r = 2.436, p = 0.013) best 
predicted sTfR independently in patients. Thus, sTfR is a useful marker for erythropoiesis. 
The elevate sTfR in these patients indicate that the transfusion regimen used was inadequate 
to suppress ineffective erythropoiesis. Hb levels may not be the best target for monitoring 
transfusion treatment in β-thalassaemia intermedia patients, but the use of sTfR is helpful in 
individualising transfusion regimens. 
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